Vericel (VCEL) Current Deferred Revenue (2015 - 2018)
Vericel (VCEL) reported Current Deferred Revenue of $566000.0 for Q4 2018, up 34.76% on a YoY basis from $420000.0 in Q4 2017, and up 5.99% sequentially from $534000.0 in Q3 2018.
Vericel (VCEL) Current Deferred Revenue (2015 - 2018) Analysis & Trends
Vericel (VCEL) has 4 years of Current Deferred Revenue data on file, last reported at $566000.0 in Q4 2018.
- For the quarter ending Q4 2018, Current Deferred Revenue rose 34.76% year-over-year to $566000.0; the trailing twelve-month figure through Dec 2018 stood at $566000.0 (up 34.76% YoY), and the FY2018 full-year result was $566000.0, up 34.76% from the prior year.
- Current Deferred Revenue improved to $566000.0 in Q4 2018, from $534000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $566000.0 in Q4 2018 to a low of $3000.0 in Q4 2016.
- A 4-year average of $362444.4 and a median of $426000.0 in 2018 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue plunged 97.46% in 2016 and soared 13900.0% in 2017, its largest moves.
- Tracing VCEL's Current Deferred Revenue over 4 years: stood at $118000.0 in 2015, then sank by 97.46% to $3000.0 in 2016, then soared by 13900.0% to $420000.0 in 2017, then surged by 34.76% to $566000.0 in 2018.
- Business Quant data shows VCEL's Current Deferred Revenue at $566000.0 in Q4 2018, $534000.0 in Q3 2018, and $503000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 566,000.00 |
| Sep 30, 2018 | 534,000.00 |
| Jun 30, 2018 | 503,000.00 |
| Mar 31, 2018 | 426,000.00 |
| Dec 31, 2017 | 420,000.00 |
| Dec 31, 2016 | 3,000.00 |
| Sep 30, 2016 | 232,000.00 |
| Jun 30, 2016 | 460,000.00 |
| Dec 31, 2015 | 118,000.00 |